Literature DB >> 7024580

Treatment of chancroid. Comparison of sulfamethoxazole-trimethoprim with recommended therapies.

J E Fitzpatrick, H Tyler, N D Gramstad.   

Abstract

Thirty-five men with chancroid were randomly treated with oral sulfisoxazole, sulfisoxazole and tetracycline, sulfamethoxazole-trimethoprim, or intramuscular streptomycin. The highest rate of cures were obtained in 13 of 13 patients treated with streptomycin and in ten of ten patients treated with sulfamethoxazole-trimethoprim. Only seven of nine patients treated with sulfisoxazole and five of eight treated with sulfisoxazole and tetracycline were cured. We conclude that the sulfamethoxazole-trimethoprim combination is as efficacious as streptomycin and probably superior to sulfisoxazole and tetracycline in the treatment of chancroid.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7024580     DOI: 10.1001/jama.246.16.1804

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  3 in total

1.  Susceptibility of 40 Haemophilus ducreyi strains to 34 antimicrobial products.

Authors:  L Slootmans; D A Vanden Berghe; E Van Dyck; P Piot
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

2.  Isolation and rapid identification of Haemophilus ducreyi.

Authors:  P Hannah; J R Greenwood
Journal:  J Clin Microbiol       Date:  1982-11       Impact factor: 5.948

Review 3.  Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Authors:  G P Wormser; G T Keusch; R C Heel
Journal:  Drugs       Date:  1982-12       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.